N-myc, a cellular gene bearing homology to the c-myc protooncogene, is frequently amplified and overexpressed in a highly restricted set of related tumors, most notably neuroblastomas and retinoblastomas. We have examined the possibility that N-myc may play a causal role in the genesis of these tumors by defining its ability to transform primary cells in tissue culture. Using an N-myc expression construct capable of producing constitutively deregulated levels of full-length murine N-myc mRNA, we demonstrate that a deregulated N-myc gene can cooperate with the activated Ha-ras oncogene to cause tumorigenic conversion of normal embryonic fibroblasts in a manner indistinguishable from the deregulated c-myc oncogene. Cell lines established from Nmyc/ras-transformed foci express high levels of the N-myc gene, and such lines are similar to c-myc/ras transformants in their ability to grow in soft agar and cause tumors in syngeneic rats. These results illustrate that N-myc does encode a c-myc-like transforming activity and that this transforming activity is not specific for the very restricted set of tumors in which N-myc is normally amplified or overexpressed.
The cellular protooncogene c-myc appears to be involved in the growth and division of a wide variety of normal cells (1) (2) (3) (4) (5) . Deregulation of c-myc expression has been noted in a large number of different tumors (6) (7) (8) (9) (10) (11) (12) , suggesting that aberrant c-myc expression can contribute to the development of neoplasia. Biological test systems, in which constitutively deregulated c-myc genes were introduced into cells in culture or into transgenic mice, have verified that altered c-myc expression can play a direct role in the development of malignant transformation (13) (14) (15) . For example, the malignant transformation ofprimary rat embryo fibroblasts (REFs) requires the cooperative actions of an overexpressed c-myc gene and a mutant ras oncogene (either Ha-ras or N-ras) (13) . It is thought that the two oncogenes provide distinct transforming functions, with the c-myc gene satisfying an "establishment" or "immortality" requirement and the ras gene conferring morphological transformation and loss of contact inhibition. Two viral oncogenes, adenovirus EJA and polyoma virus large T, and a single cellular gene, p53, have the capability to substitute for c-myc in a primary cell transformation assay, although the p53 gene appears much weaker than c-myc in its ability to compare with ras (13, (16) (17) (18) (19) .
N-myc is a cellular gene bearing DNA sequence homology to c-myc. It is frequently amplified and overexpressed in a highly restricted set of related tumors, most notably neuroblastomas and retinoblastomas (20) (21) (22) (23) (24) (25) . Furthermore, N-myc gene amplification in primary neuroblastomas corre- lates with both tumor stage and the ability of these tumors to grow in vitro as established cell lines (24) . Here we verify that altered N-myc expression can play a direct role in tumor development by demonstrating that an N-myc expression construct can cooperate with the activated Ha-ras oncogene to malignantly transform dormal embryonic fibroblasts in a manner indistinguishable from the deregulated c-myc oncogene. This illustrates that N-myc encodes a c-myc-like transforming activity and that this transforming activity is not specific for the very restricted set of tumors in which N-myc is normally amplified or overexpressed.
MATERIALS AND METHODS
Preparation and Transfection of REFs. Primary cultures of REFs were prepared as described elsewhere (26) from 12-to 14-day Fischer rat embryos; 3-4 days later the cells were frozen at -70'C with 10% (vol/vol) glycerol. To prepare for a transfection cells were thawed, then replated after 3-4 days at 1 x 106 cells per 10-cm plate in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum.
DNA was introduced into REFs by calcium phosphate precipitation as described previously (27, 28) , using [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] ,g of 3T3 carrier DNA with 2 uzg of each of the appropriate plasmid DNAs per plate. The cultures were re-fed 6-9 hr after transfection and split 24 hr after the transfection into either three (experiments 1 and 2) or four (experiment 3) plates. Assuming that limited cell division occurs in the 24 hr after the transfection, each plate after this final passage contains independent transformants. This was verified by DNA analysis of isolated transformants (data not shown). The various plasmids used in the REF transfections are as follows: pT24-ras contains the mutant Ha-ras oncogene previously described (29) ; pKO-myc, kindly provided by Daniel Birnbaum, is a c-myc expression construct in which transcription of the second and third exons of c-myc is driven from a simian virus 40 promoter; the N-myc constructs are described below and in Fig. 1 (31) . The genomic 7.7-kilobase (kb) EcoRI DNA fragment containing the murine N-myc gene was obtained by screening this library with a human N-myc probe (NB-19-21) (ref. 21 ). This 7.7-kb fragment was subcloned in the plasmid vector pUC9 and in the retroviral vector described below by methods previously described (31) .
Analysis of RNA and DNA. Our procedures for RNA and DNA preparation, gel electrophoresis, and transfer to nitrocellulose membranes have been described in detail elsewhere (31, 32) . For detection of oncogene RNA or DNA sequences we utilized a nick-translated ras probe prepared from an internal 2.9-kb Sac I fragment isolated from the mutant ras gene T24 (ref. 29) , a c-myc probe prepared from an internal 1.4-kb Xho I fragment isolated from a murine c-myc cDNA clone (ref. 33) , and a murine N-myc cDNA probe (unpublished data). Nick-translations and hybridization procedures were performed as previously described (31, 32) .
Manipulations of Retroviral Vectors. Viral stocks of pRVNmycl and pRV-Nmyc2 (see below) were collected from the supernatants of NIH 3T3 murine cells in which these vectors had been introduced by DEAE-dextran cotransfection with Moloney murine leukemia virus helper DNA by the methods described by Lobel and Goff (34). The viral stocks were then used to infect 3T3 cells, from which poly(A)+ RNA was isolated.
Similarly, c-myc requires a cotransfected mutant ras gene to transform REFs, and the optimal expression ofthe c-myc/ras transforming activity requires that the c-myc gene be driven directly by a viral promoter (13) . The pRV-Nmycl/ras foci appeared with the same frequency and kinetics as c-myc/ras foci produced from simultaneous transfections (see Table 1 , experiments 1 and 2). In both cases dense foci, which became noticeable about 9 days after the transfection, continued to expand into and eventually displaced the monolayer of normal fibroblasts. Foci from each set were picked, gradually expanded, and finally plated onto large culture dishes. Both N-myc and c-myc foci propagated at the same rate (7 of 9 N-myc and 6 of 9 c-myc foci revealed predominately transformed cells at the end of the above isolation procedure). Morphologically the N-myc and c-myc foci were quite similar macroscopically ( Fig. 2A) and microscopically ( Fig. 2 B and  C) . The predominant phenotypes of the propagated transformed cell lines were quite similar for N-myc and c-myc and consisted of markedly transformed cells, many of them rounded and floating (Fig. 2D) . These lines were malignantly transformed as judged by their anchorage-independent growth in soft agar and ability to cause tumors in young syngeneic rats (Table 1) . Tumors caused by either the N-myc or the c-myc transformants grew rapidly, eventually killing the host animal within 2-3 weeks.
Analysis (35) . Because NB-19-21 and pNl.8 contain sequences homologous to the second and third exons of c-myc, the N7.7 fragment encompasses the murine N-myc region corresponding to the known translated regions of c-myc (33, (36) (37) (38) ; mapping the locations of these c-myc homologous regions in N7.7 defined the transcriptional orientation of the N-myc gene (see legend to Fig. 1 ). DNA probes isolated from N7.7 identify a 2.9-kb murine N-myc message that is expressed in a restricted set of mouse cell lines and tissues, including neuroblastomas and developing neural tissue (unpublished data). The N7.7 DNA segment was inserted into a retroviral vector between two directly repeated Moloney murine leukemia virus long terminal repeats (LTRs) to provide the N-myc clone with a constitutive promoter, donor splice site, polyadenylylation signals, and enhancer sequences, any or all of which might be required for constitutive N-myc expression. The N7.7 fragment was inserted into this vector in both transcriptional orientations (Fig. 1B) .
Cooperation of N-myc with Mutant Ha-ras. pRV-Nmycl, which contains the N-myc gene in the same transcriptional orientation as the flanking LTRs, was not able to transform REFs None -0/4 0/4 The data for the first three columns are presented as the number of plates with positive foci compared to the total number of plates each particular transfection was finally divided into; due to the way the cells were passaged after transfection, each plate in the final passage has independent transformants (see Materials and Methods). At 2 weeks after transfection each positive plate had 1-5 foci, whereas at 4 weeks each positive plate had 5-20 foci; presumably some of these were due to metastases. Cell lines derived from c-myc/ras foci (two lines examined) or N-myc/ras foci (four lines examined) were assayed for both colony formation in soft agar and the ability to cause tumors in young syngeneic rats; each line assayed for tumorigenicity was injected into two rats. As a nontransfected control for these assays (bottom line) we used REFs propagated in culture to obtain sufficient numbers of cells. Both the colonies in soft agar and the tumors in the rats appeared and grew at approximately the same rate for either the N-myc/ras or c-myc/ras transformants. These tumors were noted in all cases within 1 week of cell injection, grew rapidly, and resulted in the death of the host animal within 2-3 weeks.
endogenous ras genes in untransformed REFs, the NIH 3T3 murine fibroblast cell line, and newborn mouse brain tissue (Fig. 3A) . Normal REFs and all the lines examined expressed their endogenous c-myc genes, but at low and variable levels; only the lines actually produced by c-myc/ras cotransfection produced very high levels of c-myc, and this expression occurred from the introduced c-myc construct (expression of (Fig. 3C) ; the lack of detectable N-myc expression in normal REFs is consistent with the highly tissue-specific expression of N-myc in normal cells (unpublished data) and in tumors (23) . Fig. 3C ). Furthermore, this transcript also does not hybridize with retroviral vector sequences (data not shown), and equal levels of a normalsized N-myc mRNA are produced when NIH 3T3 cells are infected with viral stocks of either pRV-Nmycl or pRVNmyc2 (Fig. 4) . Together, these observations suggest that the N7.7 fragment contains all the coding information necessary to produce a full-length murine N-myc mRNA and that the adjacent LTRs in pRV-Nmycl provide only an enhancer function that allows high-level expression from the normal N-myc promoter in inappropriate cells. The LTR enhancing function appears to be independent of its orientation with respect to N-myc, as is seen with other genes. Although pRV-Nmyc2 seems as effective as pRV-Nmycl in producing normal N-myc mRNA in 3T3 cells, we 
